JNJ-42847922 for depression
This study is completed in the United States, in France, in Bulgaria, .... It is testing JNJ-42847922 for depression.
In United States
Compare studies and check their requirements with the research team.
This study is completed in the United States, in France, in Bulgaria, .... It is testing JNJ-42847922 for depression.
In United StatesThis study is completed in the United States. It is testing NBI-1070770 for depression.
In United StatesThis study is completed in the United States, in Hungary, in Romania, .... It is testing SEP-363856 for schizophrenia.
In United StatesThis study is completed in the United States. It is testing SPN-810 for ADHD.
In United StatesThis study is completed in the United States. It is testing Two Doses of PF-03654746 for ADHD.
In United StatesThis study is completed in the United States, in Bulgaria, in India, .... It is testing efficacy of Paliperidone Palmitate for schizophrenia.
In United StatesThis study is completed in the United States and in China. It is testing flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.
In United StatesThis study is completed in the United States. It is testing SEP-363856 for Schizophrenia.
In United StatesThis study is completed in the United States, in France, in Canada, .... It is testing efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.
In United StatesThis study is completed in the United States, in Czechia, in Germany, .... It is testing efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.
In United StatesThis study is completed in the United States, in France, in the United Kingdom, .... It is testing efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.
In United StatesThis study is completed in the United States. It is testing Overall Effects of Treatment With Abbreviated CT-156 for schizophrenia.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.